Multiple Sclerosis

Lifestyle physical activity should be as central to the health-promoting habits of patients with multiple sclerosis (MS) as exercise training, according to one expert.
Read More

New evidence from a phase 2 clinical trial suggests that ofatumumab—a monoclonal antibody used to treat B-cell–related hematologic malignancies—may be beneficial for the treatment of patients with relapsing forms of multiple sclerosis (MS). In this new study, ofatumumab, given twice by infusion 2 weeks apart, was safe and well tolerated in patients with relapsing-remitting MS (RRMS) and reduced the number of new magnetic resonance imaging (MRI) lesions characteristic of the disease.
Read More

Page 5 of 5

Subscribe to Value-Based Care in Neurology

Stay up to date with the latest news in neurology by subscribing to receive the free VBCN e‑Newsletter.